HealthEquity Earnings Call Transcripts
Fiscal Year 2027
-
Q1 FY27 saw strong revenue and margin growth, driven by robust HSA asset expansion, digital engagement, and AI-enabled efficiencies. Raised full-year guidance and a $1B increase in share repurchase authorization reflect confidence in durable growth.
Fiscal Year 2026
-
The meeting established a quorum and approved all proposals, including director elections, auditor ratification, executive compensation, and equity plans. No shareholder questions were submitted, and official voting results will be filed in a Form 8-K.
-
Fiscal 2026 delivered record HSA sales, strong revenue and margin growth, and robust shareholder returns. AI and digital initiatives drove operational efficiency, while new legislation expanded the addressable market. Fiscal 2027 guidance was raised, reflecting continued momentum.
-
Management outlined a strategy focused on digital transformation, AI-driven efficiency, and expanding HSA access, with new policy changes and marketplace offerings driving growth. Financial guidance targets 7% revenue growth, supported by strong engagement and disciplined capital allocation.
-
Q3 fiscal 2026 saw 7% revenue growth, 806% net income increase (due to a prior-year legal settlement), and 20% higher adjusted EBITDA. HSA assets rose 15% to $34B, and guidance for fiscal 2026 was raised across all key metrics.
-
Q2 saw 9% revenue growth, 67% higher net income, and record margins, driven by HSA asset growth and operational efficiencies. New legislation expands HSA eligibility, and ongoing tech investments are reducing costs and fraud. Fiscal 2026 guidance was raised.
-
Q1 FY26 saw double-digit revenue and EBITDA growth, improved gross margin, and strong HSA asset gains. Fraud costs dropped sharply due to new security measures, and guidance for FY26 was raised. Pending legislation could expand the HSA market by 20 million families.
Fiscal Year 2025
-
Panelists discussed the challenges and progress in empowering healthcare consumers, highlighting the need for better price transparency, personalized tools, and aligned financial incentives. AI and digital platforms are improving navigation and engagement, while policy and benefit design innovations aim to control costs and promote preventive care.
-
Q4 and FY25 saw robust growth in revenue, HSAs, and assets, with record new account openings and strong client retention. Guidance for FY26 anticipates continued revenue and EBITDA growth, ongoing investments in technology and security, and normalization of service costs in the year's second half.
-
Record HSA growth and asset expansion were highlighted, with a focus on digital innovation, education, and legislative opportunities to drive further market penetration. Strategic M&A and a renewed emphasis on culture and technology under new leadership aim to sustain market leadership.
-
Q3 saw 21% revenue growth, 24% adjusted EBITDA growth, and strong HSA asset expansion. FY25 and FY26 guidance reflects continued margin improvement, robust cash flow, and ongoing share repurchases. Legislative momentum for HSA/HOPE expansion could significantly increase the addressable market.
-
Q2 delivered robust double-digit growth in revenue, EBITDA, and HSA assets, driven by organic sales and the BenefitWallet acquisition. Guidance for FY2025 was raised, with continued focus on digital transformation, enhanced rates, and capital returns.
-
Q1 FY25 delivered strong double-digit growth in revenue, EBITDA, and HSA assets, driven by organic sales and the BenefitWallet acquisition. Gross margin and EBITDA margin improved, and guidance for FY25 was raised, reflecting higher custodial yields and operational efficiencies.
Fiscal Year 2024
-
A CEO transition was announced, with Jon Kessler retiring and Scott Cutler set to take over in January 2025. The company remains in a strong financial and strategic position, with ongoing innovation and a focus on consumer empowerment. Legislative developments may further support growth.